Woods v. GlaxoSmithKline LLC

Filing 13

Judge F. Dennis Saylor, IV: ORDER entered granting 10 Motion for Order to Show Cause and 12 Motion to Withdraw (FDS, law1)

UNITED STATES DISTRICT COURT
DISTRICT OF MASSACHUSETTS
_________________________________________
)
CHARLENE WOODS, individually and on
)
behalf of A.P., her minor child,
)
)
Plaintiffs,
)
)
v.
)
)
GLAXOSMITHKLINE LLC,
)
)
Defendant.
)
__________________________________________)

Civil Action No.
17-11853-FDS

ORDER TO SHOW CAUSE
AND GRANTING MOTION TO WITHDRAW
SAYLOR, J.
On May 26, 2016, this Court issued MDL Order No. 11, which required each plaintiff to
complete a Plaintiff Fact Sheet. (Docket No. 252 at ¶ 14). That Order also required plaintiffs to
include signed declarations and duly executed authorizations with their fact sheets. (Id.).
Furthermore, the Court ordered that “questions on the fact sheets shall be treated as
interrogatories under Rule 33 of the Federal Rules of Civil Procedure, and shall be subject to the
rules applicable to such interrogatories . . . .” (Id. at ¶ 17).
It appears that plaintiffs have failed to comply with MDL Order No. 11. On February 27,
2018, GlaxoSmithKline LLC filed a motion to compel compliance with MDL Order No. 11. On
March 14, 2018, attorney Daniel C. Burke, counsel for plaintiffs, filed a motion to withdraw as
attorney due to his inability to secure plaintiffs’ compliance with discovery obligations.
The motion to withdraw is GRANTED, effective April 4, 2018, or upon the filing of an
appearance by a new counsel or a written notice by plaintiffs that they intend to proceed pro se.

1

New counsel, or plaintiffs proceeding pro se, are ORDERED to show cause in writing on or
before that date, April 4, 2018, why this case should not be dismissed for failure to comply with
discovery obligations. If good cause is not shown by that date, this action will be dismissed
pursuant to Rule 37(b)(2)(A)(v).
So Ordered.

/s/ F. Dennis Saylor
F. Dennis Saylor IV
United States District Judge

Dated: March 14, 2018

2